Post Approval Study of the remedē System

NCT03425188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-04-22

Study results available
· View outcomes & findings →

Summary

Prospective, single arm cohort study to evaluate the long-term safety, long-term effectiveness, and survival rate in subjects implanted with the remedē System.

Conditions

  • Central Sleep Apnea

Sponsors & Collaborators

  • Respicardia, Inc.

    lead INDUSTRY

Principal Investigators

  • Robin Germany, MD · Respicardia, Inc.

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-28
Primary Completion
2020-08-04
Completion
2020-08-04

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03425188 on ClinicalTrials.gov